STING agonist-20
STING agonist-20 (compound 95) is a potent STING agonist used in the synthesis of XMT-2056. STING agonist-20 can be used as a vaccine adjuvant in the study of cancer and other inflammatory, immune diseases[1].
Product Specifications
CAS Number
2591300-72-8
UNSPSC
12352005
Target
STING
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/sting-agonist-20.html
Concentration
10mM
Purity
99.79
Solubility
DMSO : 80 mg/mL (ultrasonic)
Smiles
O=C(C1=C(N=C(O1)C)CC)NC2=NC3=CC(C(N)=O)=CN=C3N2C/C=C/CN4C5=C(OCCCO)C=C(C(N)=O)C=C5N=C4NC(C6=C(N=C(O6)C)CC)=O
Molecular Formula
C36H39N11O8
Molecular Weight
753.76
References & Citations
[1]R. DUVALL J, et al., Sting agonist compounds and methods of use. US20210032269
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MCM7 (Proliferation Marker) (MCM7/1469), CF640R conjugate, 0.1mg/mL
IGF1 Receptor (IGF1R) (NM_000875) Human Recombinant Protein
